Assessing cancer clinical trials: Will your patient benefit from a 'breakthrough'?

ABSTRACTCancer patients and their families often ask their primary care physicians if a new treatment reported in the news can help them. Physicians familiar with the long and complicated process of oncologic clinical trials are in the best position to assess the potential for clinical benefit from a new antineoplastic therapy.